| 臺大學術典藏 |
2018-09-10T08:29:54Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang, J.-W. and Yen, C.-J. and Wu, H.-Y. and Chiang, C.-K. and Cheng, H.-T. and Lien, Y.-C. and Hung, K.-Y. and Tsai, T.-J.; CHIH-KANG CHIANG; CHUNG-JEN YEN; TUN-JUN TSAI; JENQ-WEN HUANG; KUAN-YU HUNG; HUI-TENG CHENG |
| 國立交通大學 |
2014-12-08T15:35:29Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Ko, Jen-Chung; Chiu, Hsien-Chun; Syu, Jhan-Jhang; Jian, Yi-Jun; Chen, Chien-Yu; Jian, Yun-Ting; Huang, Yi-Jhen; Wo, Ting-Yu; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T14:53:50Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Ko, J.-C. and Chiu, H.-C. and Syu, J.-J. and Jian, Y.-J. and Chen, C.-Y. and Jian, Y.-T. and Huang, Y.-J. and Wo, T.-Y. and Lin, Y.-W.; JEN-CHUNG KO; Chiu, Hsien-Chun; Syu, Jhan-Jhang; Jian, Yi-Jun; Chen, Chien-Yu; Jian, Yun-Ting; Huang, Yi-Jhen; Wo, Ting-Yu; Lin, Yun-Wei |
| 臺大學術典藏 |
2021-03-11T07:58:33Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:24Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Jen-Chang Ko;Chiu H.-C.;Syu J.-J.;Jian Y.-J.;Chen C.-Y.;Jian Y.-T.;Huang Y.-J.;Wo T.-Y.;Lin Y.-W.; JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:38Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
Jen-Chang Ko;Chiu H.-C.;Syu J.-J.;Jian Y.-J.;Chen C.-Y.;Jian Y.-T.;Huang Y.-J.;Wo T.-Y.;Lin Y.-W.; JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:47Z |
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
1995 |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Pu Y.-S.;Hsieh T.-S.;Tsai T.-C.;Cheng A.-L.;Chang-Yao Hsieh;Su I.-J.;Lai M.-K.; Pu Y.-S.; Hsieh T.-S.; Tsai T.-C.; Cheng A.-L.; CHANG-YAO HSIEH; Su I.-J.; Lai M.-K. |
| 臺大學術典藏 |
2021-02-02T00:47:12Z |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Yeong-Shiau Pu;Hsieh T.-S.;Tsai T.-C.;Cheng A.-L.;Hsieh C.-Y.;Su I.-J.;Lai M.-K.; YEONG-SHIAU PU; Hsieh T.-S.; Tsai T.-C.; Cheng A.-L.; Hsieh C.-Y.; Su I.-J.; Lai M.-K. |
| 臺大學術典藏 |
2021-09-01T02:02:44Z |
Tamoxifen Enhances the Chemosensitivity of Bladder Carcinoma Cells
|
Pu Y.-S.; Hsieh T.-S.; Tsai T.-C.; ANN-LII CHENG; Hsieh C.-Y.; Su I.-J.; Lai M.-K. |
| 國家衛生研究院 |
2020-05-29 |
Tamoxifen for amyotrophic lateral sclerosis: A randomized double-blind clinical trial
|
Chen, PC;Hsieh, YC;Huang, CC;Hu, CJ |
| 國立交通大學 |
2015-07-21T11:20:28Z |
Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells
|
Liu, Chun-Yu; Hung, Man-Hsin; Wang, Duen-Shian; Chu, Pei-Yi; Su, Jung-Chen; Teng, Tsung-Han; Huang, Chun-Teng; Chao, Ting-Ting; Wang, Cheng-Yi; Shiau, Chung-Wai; Tseng, Ling-Ming; Chen, Kuen-Feng |
| 國家衛生研究院 |
2006-11 |
Tamoxifen induces degradation of the o6-methylguanine DNA methyltransferase protein via the ubiquitin-dependent proteosome pathway in human cancer cells
|
Kuo, CC;Liu, JF;Chang, JY |
| 中國醫藥大學 |
2001.01 |
Tamoxifen inhibits arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human leukemia HL-60 cells
|
(Ko-Hsiu Lu); (Keh-Liang Lin); 夏德椿(Te-Chun Hsia); (Jing-Gung Chung) |
| 國立成功大學 |
2020 |
Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells
|
Chang, Y.-C.;Cheung, Cheung C.H.A.;Kuo, Y.-L. |
| 輔英科技大學 |
2017-03-01 |
Tamoxifen use and acute pancreatitis: A population-based cohort study
|
Hsu, Fan-Gen;Hsieh, Yow-Wen;Sheu, Ming-Jyh;Lin, Che-Chen;Lin, Cheng-Li;Hsu, Chung Y.;Lee, Chang-Yin;Chang, Mei-Yin;Chang, Kuang-Hsi |
| 國立臺灣大學 |
2005 |
Tamoxifen 經由細胞凋亡抑制腹膜纖維化
|
黃政文 |
| 高雄醫學大學 |
1999 |
Tamoxifen可於不含雌性素受體的肺癌細胞誘導p21waf1及p27kip1的表現
|
李德修;莊麗月;洪文俊 ; Te-Hsiu Lee;Lea-Yea Chuang;Wen-Chun Hung |
| 國立臺灣大學 |
2002-07-31 |
Tamoxifen引起神經膠質瘤細胞凋亡時所造成的c-Jun-N-terminal kinase 1 的下游訊息通路的變化
|
林瑞明 |
| 國立臺灣大學 |
2004 |
Tamoxifen抑制腹膜纖維化的分子機制
|
黃政文 |
| 高雄醫學大學 |
2014 |
Tamoxifen治療乳癌個案與非酒精性脂肪肝之風險及相關因素探討
|
潘湘如; Pan, Hsiang-Ju |
| 國立臺灣大學 |
2002 |
Tamoxifen預防腹膜纖維化之機轉及其在生體療效之研究(1/3)
|
蔡敦仁 |
| 國立臺灣大學 |
2003 |
Tamoxifen預防腹膜纖維化之機轉及其在生體療效之研究(2/3)
|
蔡敦仁 |
| 國立臺灣大學 |
2004 |
Tamoxifen預防腹膜纖維化之機轉及其在生體療效之研究(3/3)
|
蔡敦仁 |
| 中原大學 |
2009-12 |
Tamper Detection and Inpainting for Medical Images Using Recoverable Watermarking Techniques
|
Yeh, S. K.; Miaou, S. G.; Li, Y. R. |
